WILLIAM J PHD LINK
CIK 1228684 · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$162.06M
Companies
11
Total Filings
94
Lifetime Open-Market Net
-$30.21M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNSR | Director | 568,062 | $5.82 | $3.31M | $0 | 7 | 2026-06-05 |
| TARS | Director | 116,332 | $61.95 | $7.21M | -$5.18M | 18 | 2026-03-18 |
| RXST | Director | 59,103 | $4.71 | $278.4K | -$903.1K | 16 | 2025-06-04 |
| Oyster Point Pharma, Inc. (OYST) Delisted | Director | 38,008 | $11.17 | $424.5K | -$7.72M | 9 | 2022-01-07 |
| GKOS | Director | 58,300 | $126.81 | $7.39M | -$7.62M | 17 | 2021-06-07 |
| EW | Director | 17,054 | $85.11 | $1.45M | -$7.03M | 15 | 2020-05-11 |
| Vivani Medical, Inc. (EYESW) Delisted | Director | 4,608,161 | $0.22 | $1.01M | $0 | 3 | 2019-06-05 |
| EYES | Director | 4,515,622 | $26.30 | $118.77M | $0 | 2 | 2016-06-03 |
| INGN | Director | 3,695,816 | $6.40 | $23.65M | $0 | 1 | 2014-02-21 |
| HELICOS BIOSCIENCES CORP (HLCS) Delisted | 10%+ Owner | 10,709,818 | — | — | $4.38M | 1 | 2009-09-21 |
| INTRALASE CORP (ILSE) Delisted | Director | 2,338,482 | — | — | -$6.13M | 1 | 2007-01-17 |
Recent Filings · Page 4 of 10
94 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-03 | RXST | Grant (A) | +10,349 | $0 | EDGAR |
| 2022-05-31 | LNSR | Grant (A) | +4,285 | $0 | EDGAR |
| 2022-05-19 | RXST | Other (J) | −375,000 | $0 | EDGAR |
| 2022-03-17 | RXST | Other (J) | −375,000 | $0 | EDGAR |
| 2022-01-07 | Oyster Point Pharma, Inc. (OYST) Delisted | Other (J) | +6,839 | $0 | EDGAR |
| 2021-12-23 | Oyster Point Pharma, Inc. (OYST) Delisted | Other (J) | +6,838 | $0 | EDGAR |
| 2021-11-16 | TARS | Other (J) | −245,652 | $0 | EDGAR |
| 2021-10-20 | Oyster Point Pharma, Inc. (OYST) Delisted | Sell (S) | −550,000 | -$8.16M | EDGAR |
| 2021-08-05 | RXST | Mixed | +2,048,028 | $500.0K | EDGAR |
| 2021-08-02 | RXST | Grant (A) | +5,859 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.